These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 7954295)
21. The future of basic science research and stroke: hubris and translational stroke research. Lyden P Int J Stroke; 2011 Oct; 6(5):412-3. PubMed ID: 21951405 [No Abstract] [Full Text] [Related]
22. Report on financing the new model of family medicine. Spann SJ; Ann Fam Med; 2004 Dec; 2 Suppl 3(Suppl 3):S1-21. PubMed ID: 15654084 [TBL] [Abstract][Full Text] [Related]
23. [Cancer research at the transition from bench to bedside]. Wiestler OD; Rautenstrauch J Med Klin (Munich); 2006 Feb; 101(2):153-9. PubMed ID: 16501913 [TBL] [Abstract][Full Text] [Related]
24. The economic evaluation of cancer treatments and programmes. Goddard M; Drummond M Eur J Cancer; 1991; 27(10):1191-6. PubMed ID: 1835583 [No Abstract] [Full Text] [Related]
25. [Significance of networking for clinical research in the future]. Hehlmann R Onkologie; 2001 Aug; 24(4):380-4. PubMed ID: 11574767 [No Abstract] [Full Text] [Related]
26. Taking quality of life into account in health economic analyses. Weeks J J Natl Cancer Inst Monogr; 1996; (20):23-7. PubMed ID: 8750463 [TBL] [Abstract][Full Text] [Related]
27. Clinical studies with traditional Chinese medicine in the past decade and future research and development. Jiang M; Yang J; Zhang C; Liu B; Chan K; Cao H; Lu A Planta Med; 2010 Dec; 76(17):2048-64. PubMed ID: 20979016 [TBL] [Abstract][Full Text] [Related]
28. Translating clinical trials into meaningful outcomes. LoRusso PM; Schnipper LE; Stewart DJ; Boerner SA; Averbuch SD; Wolf W Clin Cancer Res; 2010 Dec; 16(24):5951-5. PubMed ID: 21169247 [TBL] [Abstract][Full Text] [Related]
30. Breakout I. Ethical considerations. McKenna RJ; Laszlo J; Durant J; Hermann JF; Huguley C; Leventhal B; Roach E; Siegler M Cancer; 1990 May; 65(10 Suppl):2407-8. PubMed ID: 2185876 [No Abstract] [Full Text] [Related]
31. Three questions about costs and cancer clinical trials. Chirikos TN Cancer Control; 2003; 10(1):71-8. PubMed ID: 12598857 [No Abstract] [Full Text] [Related]
32. A Time-Trend Economic Analysis of Cancer Drug Trials. Cressman S; Browman GP; Hoch JS; Kovacic L; Peacock SJ Oncologist; 2015 Jul; 20(7):729-36. PubMed ID: 26032135 [TBL] [Abstract][Full Text] [Related]
33. The project data sphere initiative: accelerating cancer research by sharing data. Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994 [TBL] [Abstract][Full Text] [Related]
34. Interactive financial decision support for clinical research trials. Holler B; Forgione DA; Baisden CE; Abramson DA; Calhoon JH J Health Care Finance; 2011; 37(3):25-37. PubMed ID: 21528831 [TBL] [Abstract][Full Text] [Related]
35. Special aspects of cancer prevention trials. Nixon DW Cancer; 1994 Nov; 74(9 Suppl):2683-6. PubMed ID: 7954286 [TBL] [Abstract][Full Text] [Related]
36. Strategies used in the clinical trials of gene therapy for cancer. Ajith TA J Exp Ther Oncol; 2015; 11(1):33-9. PubMed ID: 26259388 [TBL] [Abstract][Full Text] [Related]
37. [Quality assurance in medicine. Current status, future requirements]. Künzel U Herz; 1996 Dec; 21(6):341-6. PubMed ID: 9081903 [TBL] [Abstract][Full Text] [Related]